Chardonnay grape seed products for nonalcoholic fatty liver disease
Embodiments described herein provide for uses of grape products, such as Chardonnay grape products and grape seed flour, for use in promoting a healthy liver, promoting healthy fat content in a liver, for treating or preventing NAFLD, and other embodiments and uses as described herein.
1. A method of treating non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) in a mammal in need therefor, comprising administering to the mammal an amount of a Chardonnay grape seed flour or a Chardonnay grape seed extract effective to treat NAFLD or NASH.
2. The method of claim 1 , wherein the Chardonnay grape seed flour or a Chardonnay grape seed extract reduces the amount of fat deposited in the liver.
3. The method of claim 1 , wherein the Chardonnay grape seed extract is a methanol or ethanol extract.
4. The method of claim 1 , wherein the Chardonnay grape seed flour or a Chardonnay grape seed extract is administered in effective amount of about 1 mg to about 15,000 mg.
5. The method of claim 1 , wherein the mammal is a human, companion animal, domestic pet, husbanded animal, or livestock.
6. The method of claim 1 , wherein the method further comprises at least one additional compound.
7. The method of claim 6 , wherein the at least one additional compound is an antioxidant, an anti-cholesterol medication, anti-glycemic compound, or an insulin sensitizer.
8. The method of claim 6 , wherein the at least one additional compound is vitamin E, vitamin A, vitamin C, a carotenoid, lipoic acid, ubiquinol, ubiquinone, or glutathione.
9. The method of claim 1 , wherein the mammal is administered the Chardonnay grape seed flour.
10. The method of claim 1 , wherein the mammal is administered the Chardonnay grape seed extract.
11. A method of reducing hepatic steatosis, steatohepatitis, or hepatic fibrosis in a mammal in need thereof, comprising administering to the mammal an amount of a Chardonnay grape seed flour or a Chardonnay grape seed extract effective to reduce hepatic steatosis, steatohepatitis, or hepatic fibrosis.
12. The method of claim 11 , wherein the mammal has been identified as having non-alcoholic fatty liver disease.
13. A method of:
reducing oxidative stress in a liver of a mammal in need thereof, comprising administering to the mammal an amount of a Chardonnay grape seed flour or a Chardonnay grape seed extract effective to reduce or prevent oxidative stress in the mammal's liver;
protecting, supporting, or enhancing, cytochrome P450 and/or Phase II enzymatic detoxification system in a liver of a mammal in need thereof, comprising administering to the mammal an amount of a Chardonnay grape seed flour or a Chardonnay grape seed extract effective to protect, support, or enhance cytochrome P450 and/or Phase II enzymatic detoxification system in the mammal's liver; or
of increasing production of antioxidants in a mammal, in need thereof, the method comprising administering to the mammal an amount of a Chardonnay grape seed flour or a Chardonnay grape seed extract effective to increase the production of antioxidants in the mammal.
14. The method of claim 13 , wherein the method reduces or prevents lipid peroxidation.
15. The method of claim 13 , wherein the antioxidant is glutathione, superoxide dismutase, or catalase.
16. The method of claim 13 , wherein the mammal is administered the Chardonnay grape seed flour.
17. The method of claim 13 , wherein the mammal is administered the Chardonnay grape seed extract.